[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Integra Lifesciences (IART)

Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
3 Stocks Under $50 with Questionable Fundamentals

3 Stocks Under $50 with Questionable Fundamentals

MAT : 14.57 (-0.07%)
PZZA : 23.40 (+0.73%)
IART : 17.66 (unch)
3 Value Stocks We Steer Clear Of

3 Value Stocks We Steer Clear Of

XPOF : 5.08 (-0.20%)
IART : 17.66 (unch)
AAL : 14.33 (-0.69%)
2 Russell 2000 Stocks with Solid Fundamentals and 1 We Find Risky

2 Russell 2000 Stocks with Solid Fundamentals and 1 We Find Risky

BDC : 136.47 (-0.81%)
IART : 17.66 (unch)
SM : 36.08 (+1.69%)
5 Must-Read Analyst Questions From Integra LifeSciences’s Q2 Earnings Call

5 Must-Read Analyst Questions From Integra LifeSciences’s Q2 Earnings Call

IART : 17.66 (unch)
IART Q2 Deep Dive: Flat Revenue, Margin Pressure, and Operational Realignment Shape Outlook

IART Q2 Deep Dive: Flat Revenue, Margin Pressure, and Operational Realignment Shape Outlook

IART : 17.66 (unch)
Why Integra LifeSciences (IART) Shares Are Sliding Today

Why Integra LifeSciences (IART) Shares Are Sliding Today

IART : 17.66 (unch)
Integra: Q2 Earnings Snapshot

Integra: Q2 Earnings Snapshot

IART : 17.66 (unch)
Integra LifeSciences’s (NASDAQ:IART) Q2 CY2026 Earnings Results: Revenue In Line With Expectations

Integra LifeSciences’s (NASDAQ:IART) Q2 CY2026 Earnings Results: Revenue In Line With Expectations

IART : 17.66 (unch)
Integra LifeSciences Reports Second Quarter 2026 Financial Results

PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the second...

IART : 17.66 (unch)
Integra LifeSciences (IART) To Report Earnings Tomorrow: Here Is What To Expect

Integra LifeSciences (IART) To Report Earnings Tomorrow: Here Is What To Expect

IART : 17.66 (unch)

Barchart Exclusives

Analysts Keep Hiking Intel's Revenue Forecasts and Price Targets - Is INTC Still a Buy?
Revenue forecasts for Intel in 2027 continue to rise. Moreover, analysts have been upping their price targets for INTC. With a 9% FCF margin and a 1% FCF yield, INTC appears 17% undervalued. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.